3F-NEB

3F-NEB is a synthetic compound that belongs to the class of novel psychoactive substances (NPS). It is a fluorinated derivative of the cathinone family, which are substances chemically similar to cathinone, a naturally occurring stimulant found in the khat plant. 3F-NEB is known for its stimulant and euphoric effects, which have led to its use as a recreational drug.
Chemical Properties[edit]
3F-NEB is chemically known as 3-fluoro-N-ethylbuphedrone. It is a derivative of buphedrone, with a fluorine atom replacing a hydrogen atom in the phenyl ring. This modification is believed to alter the compound's pharmacological properties, potentially increasing its potency and duration of action compared to non-fluorinated analogs.
Pharmacology[edit]
The pharmacological effects of 3F-NEB are not well-studied, but it is presumed to act as a monoamine releasing agent, similar to other cathinones. This means it likely increases the levels of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain, leading to its stimulant effects. Users report increased energy, alertness, and euphoria, but these effects can be accompanied by adverse reactions such as anxiety, paranoia, and cardiovascular issues.
Legal Status[edit]
The legal status of 3F-NEB varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting synthetic cathinones and other novel psychoactive substances.
Health Risks[edit]
The use of 3F-NEB carries significant health risks. Acute effects can include tachycardia, hypertension, hyperthermia, and seizures. Chronic use may lead to addiction, psychosis, and other long-term health issues. Due to the lack of research, the full extent of its toxicity and potential for harm is not fully understood.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian